ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,879,159 | +19.3% | 21,055 | +43.3% | 0.01% | 0.0% |
| Q1 2023 | $1,575,491 | -15.8% | 14,694 | -4.1% | 0.01% | -16.7% |
| Q4 2022 | $1,871,887 | +14.2% | 15,327 | -3.4% | 0.01% | +20.0% |
| Q3 2022 | $1,639,000 | -10.0% | 15,868 | -19.0% | 0.01% | 0.0% |
| Q2 2022 | $1,821,000 | -43.6% | 19,588 | -28.7% | 0.01% | -28.6% |
| Q1 2022 | $3,226,000 | -0.3% | 27,488 | +14.3% | 0.01% | +16.7% |
| Q4 2021 | $3,236,000 | -15.6% | 24,053 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $3,834,000 | +21.2% | 24,053 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $3,164,000 | +18.9% | 24,053 | +16.5% | 0.01% | +16.7% |
| Q1 2021 | $2,661,000 | -34.0% | 20,646 | -14.6% | 0.01% | -33.3% |
| Q4 2020 | $4,030,000 | +42.7% | 24,166 | +32.1% | 0.01% | +28.6% |
| Q3 2020 | $2,824,000 | – | 18,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 2,003,147 | $225,574,000 | 20.44% |
| RA Capital Management | 4,914,955 | $553,473,000 | 17.48% |
| Sofinnova Investments, Inc. | 1,109,874 | $124,983,000 | 11.56% |
| Eversept Partners, LP | 275,494 | $31,023,379 | 7.71% |
| Avoro Capital Advisors LLC | 1,787,000 | $201,234,000 | 6.79% |
| Orbimed Advisors | 3,287,400 | $370,194,000 | 6.22% |
| Eventide Asset Management | 1,698,648 | $191,285,000 | 6.19% |
| Logos Global Management LP | 120,000 | $13,513,000 | 5.14% |
| Ghost Tree Capital, LLC | 150,000 | $16,892,000 | 4.48% |
| Spyglass Capital Management LLC | 351,388 | $39,570,000 | 4.47% |